These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1458670)

  • 21. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
    Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
    Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [How do fungal infections "escape" treatment? Resistance and resistance mechanisms].
    Morschhäuser J
    Pharm Unserer Zeit; 2003; 32(2):124-8. PubMed ID: 12677965
    [No Abstract]   [Full Text] [Related]  

  • 23. Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses.
    Clayton YM
    Br J Dermatol; 1994 Apr; 130 Suppl 43():7-8. PubMed ID: 8186143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections.
    Seidl HP; Jäckel A; Müller J; Schaller M; Borelli C; Polak A
    Mycoses; 2015 Oct; 58(10):610-9. PubMed ID: 26334024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the mode of action of antimycotics, especially of clotrimazole (Canesten), on the ultrastructural level of human pathogenic fungi.
    Voigt WH
    Scand J Infect Dis Suppl; 1978; (16):51-8. PubMed ID: 285460
    [No Abstract]   [Full Text] [Related]  

  • 26. Antifungal activity in vitro of Ro 14-4767/002, a phenylpropyl-morpholine.
    Polak A
    Sabouraudia; 1983 Sep; 21(3):205-13. PubMed ID: 6635894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane fluidity determines sensitivity of filamentous fungi to chitosan.
    Palma-Guerrero J; Lopez-Jimenez JA; Pérez-Berná AJ; Huang IC; Jansson HB; Salinas J; Villalaín J; Read ND; Lopez-Llorca LV
    Mol Microbiol; 2010 Feb; 75(4):1021-32. PubMed ID: 20487294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of antifungal activity of naphthoquinone derivatives.
    Errante G; La Motta G; Lagana C; Wittebolle V; Sarciron ME; Barret R
    Eur J Med Chem; 2006 Jun; 41(6):773-8. PubMed ID: 16563569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current status of studies on sensitivity to antifungal agents].
    Martín Mazuelos E
    Enferm Infecc Microbiol Clin; 1992; 10(6):366-71. PubMed ID: 1391021
    [No Abstract]   [Full Text] [Related]  

  • 30. Bioavailability, skin- and nailpenetration of topically applied antimycotics.
    Stüttgen G; Bauer E
    Mykosen; 1982 Feb; 25(2):74-80. PubMed ID: 7062934
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis of some new triazoles as potential antifungal agents.
    Fahmy HT
    Boll Chim Farm; 2001; 140(6):422-7. PubMed ID: 11822232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editorial: Resistance to antifungal agents.
    Odds FC
    Fungal Genet Biol; 2010 Feb; 47(2):190. PubMed ID: 20026235
    [No Abstract]   [Full Text] [Related]  

  • 33. Relation between lipophilicity of alkyl gallates and antifungal activity against yeasts and filamentous fungi.
    Leal PC; Mascarello A; Derita M; Zuljan F; Nunes RJ; Zacchino S; Yunes RA
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1793-6. PubMed ID: 19232493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural products and antifungal drug discovery.
    Jacob MR; Walker LA
    Methods Mol Med; 2005; 118():83-109. PubMed ID: 15888937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Retention of amorolfine in the skin tissue as measured by prevention of the development of experimental dermatophytosis in guinea pigs].
    Uchida K; Yamaguchi H
    Jpn J Antibiot; 1991 Sep; 44(9):1032-41. PubMed ID: 1960853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifungal agents: an overview. Part II.
    Gupta AK; Sauder DN; Shear NH
    J Am Acad Dermatol; 1994 Jun; 30(6):911-33; quiz 934-6. PubMed ID: 7619094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal activity in rhizomes of Curcuma amada Roxb.
    Ghosh SB; Gupta S; Chandra AK
    Indian J Exp Biol; 1980 Feb; 18(2):174-6. PubMed ID: 7399598
    [No Abstract]   [Full Text] [Related]  

  • 38. Agar sublimation test for the in vitro determination of the antifungal activity of morpholine derivatives.
    Polak A; Jäckel A; Noack A; Kappe R
    Mycoses; 2004 Jun; 47(5-6):184-92. PubMed ID: 15189181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elucidation of the biosynthesis and degradation of allantofuranone by isotopic labelling and fermentation of modified precursors.
    Schüffler A; Liermann JC; Opatz T; Anke T
    Chembiochem; 2011 Jan; 12(1):148-54. PubMed ID: 21181846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of a method incorporating treatment with daunomycin for the selective isolation of slower-growing fungi.
    Sugimoto S; Watanabe Y; Isshiki K
    Biosci Biotechnol Biochem; 2008 Sep; 72(9):2385-91. PubMed ID: 18776679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.